Get the Stockscreener App
136.00
2.33%
3.3299
Transmedics Group Inc stock is traded at $136.00, with a volume of 81,501.
It is up +2.33% in the last 24 hours and down -0.55% over the past month.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
See More
Previous Close:
$132.67
Open:
$132.8
24h Volume:
81,501
Relative Volume:
0.10
Market Cap:
$4.63B
Revenue:
$531.29M
Net Income/Loss:
$71.66M
P/E Ratio:
70.33
EPS:
1.9338
Net Cash Flow:
$17.35M
1W Performance:
+11.60%
1M Performance:
-0.55%
6M Performance:
+8.46%
1Y Performance:
+72.57%
1-Day Range:
$131.00
$136.47
1-Week Range:
$120.17
$136.47
52-Week Range:
$55.00
$156.00
Transmedics Group Inc Stock (TMDX) Company Profile
Name
Transmedics Group Inc
Sector
Industry
Phone
(978) 552-0900
Address
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
135.54 | 4.53B | 531.29M | 71.66M | 17.35M | 1.9338 |
|
ABT
Abbott Laboratories
|
127.01 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.50 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
365.06 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.71 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.68 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-23-25 | Upgrade | Needham | Hold → Buy |
| Oct-13-25 | Initiated | Jefferies | Buy |
| Sep-16-25 | Initiated | Evercore ISI | Outperform |
| Sep-04-25 | Initiated | Stifel | Hold |
| Dec-17-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-22-24 | Downgrade | Needham | Buy → Hold |
| Oct-29-24 | Reiterated | Needham | Buy |
| Oct-29-24 | Reiterated | Oppenheimer | Outperform |
| Sep-24-24 | Initiated | Robert W. Baird | Outperform |
| Aug-21-24 | Initiated | Needham | Buy |
| Jun-06-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-04-24 | Initiated | Stephens | Overweight |
| Mar-28-24 | Initiated | Piper Sandler | Overweight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Aug-02-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-08-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-07-20 | Initiated | Oppenheimer | Outperform |
| May-28-19 | Initiated | Canaccord Genuity | Buy |
| May-28-19 | Initiated | Cowen | Outperform |
| May-28-19 | Initiated | JP Morgan | Overweight |
| May-28-19 | Initiated | Morgan Stanley | Equal-Weight |
View All
Transmedics Group Inc Stock (TMDX) Latest News
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Stifel maintains Hold rating on TransMedics stock amid slowing growth By Investing.com - Investing.com UK
Here's why TransMedics (TMDX) is a strong growth stock - MSN
Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Investors to Inquire about Securities Investigation - ACCESS Newswire
Trading the Move, Not the Narrative: (TMDX) Edition - Stock Traders Daily
TransMedics Group, Inc. (NASDAQ:TMDX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
TransMedics (TMDX) Sees Modest Growth in Transplant Volumes and Revenue Prospects - GuruFocus
How Is The Market Feeling About TransMedics Group Inc? - Benzinga
Piper Sandler reiterates Overweight rating on TransMedics stock By Investing.com - Investing.com Canada
TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference - Yahoo Finance
Some Confidence Is Lacking In TransMedics Group, Inc.'s (NASDAQ:TMDX) P/E - 富途牛牛
Here's Why TransMedics Group (NASDAQ:TMDX) Can Manage Its Debt Responsibly - simplywall.st
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Eastern Progress
Top 10 Most Shorted Stocks: Lucid, MARA, Hims and More - Benzinga
TransMedics Group (NASDAQ:TMDX) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Here Are My Top 2 No-Brainer Growth Stocks to Buy Now - The Globe and Mail
Here's Why TransMedics (TMDX) is a Strong Growth Stock - Yahoo Finance
TMDX INVESTORS: Kirby McInerney LLP Reminds TransMedics Group, Inc. Investors of Important Deadline and Encourages Investors to Contact the Firm - TMX Newsfile
Aug Breakouts: Is TransMedics Group Inc. stock dividend yield sustainableJuly 2025 Intraday Action & Weekly High Return Forecasts - moha.gov.vn
New TransMedics hires get stock options and units with long vesting - Stock Titan
TransMedics Stock: I Estimate An Upside Of Nearly 150% By The End Of 2028 (NASDAQ:TMDX) - Seeking Alpha
TransMedics Could Report Q4 Beat if it Maintains Monthly Organ Transplant Volume, Needham Says - marketscreener.com
TransMedics: A Stagnant Monopoly Facing Regulatory Pressure (NASDAQ:TMDX) - Seeking Alpha
Behavioral Patterns of TMDX and Institutional Flows - Stock Traders Daily
TransMedics stock could see upside from heart trial, Piper Sandler says - Investing.com Canada
Zevenbergen Capital Investments LLC Increases Stock Position in TransMedics Group, Inc. $TMDX - MarketBeat
Texas Permanent School Fund Corp Purchases 12,249 Shares of TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics Group (NASDAQ:TMDX) Rating Lowered to "Hold" at Wall Street Zen - MarketBeat
Growth Review: Is TransMedics Group Inc. stock dividend yield sustainable2025 Winners & Losers & Free Technical Pattern Based Buy Signals - Улправда
Market Leaders: Will TransMedics Group Inc. stock recover faster than peersNew Guidance & Safe Entry Trade Signal Reports - Улправда
Is TransMedics Group Inc. stock affected by interest rate hikesJuly 2025 Intraday Action & Accurate Intraday Trade Tips - DonanımHaber
Why TransMedics Group Inc. stock could outperform in 2025Weekly Investment Summary & Accurate Technical Buy Alerts - Улправда
Will TransMedics Group Inc. stock rally after Fed decisionsEarnings Trend Report & Risk Controlled Swing Alerts - DonanımHaber
Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Connect - ACCESS Newswire
3 Skyrocketing MedTech Stocks That Might Lose Steam in 2026 - Zacks Investment Research
Canaccord Genuity Maintains TransMedics Group (TMDX) Buy Recommendation - Nasdaq
TransMedics Group (NASDAQ:TMDX) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - MarketBeat
TransMedics Group (TMDX): Canaccord Genuity Raises Price Target | TMDX Stock News - GuruFocus
Analysts Are Bullish on Top Healthcare Stocks: Boston Scientific (BSX), TransMedics Group (TMDX) - The Globe and Mail
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Reach Out - ACCESS Newswire
Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt? - 富途牛牛
Is TransMedics Group, Inc.'s (NASDAQ:TMDX) ROE Of 26% Impressive? - simplywall.st
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Liontrust Investment Partners LLP Reduces Stake in TransMedics Group, Inc. $TMDX - MarketBeat
Eventide Asset Management LLC Sells 130,626 Shares of TransMedics Group, Inc. $TMDX - MarketBeat
Braidwell LP Cuts Stock Holdings in TransMedics Group, Inc. $TMDX - MarketBeat
Bellevue Group AG Reduces Stake in TransMedics Group, Inc. $TMDX - MarketBeat
(TMDX) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
2025-12-11 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Investors to Learn More About the Investigation | NDAQ:TMDX | Press Release - Stockhouse
Reasons to retain TransMedics stock in your portfolio for now - MSN
2 under-the-radar stocks that have soared this year - MSN
Transmedics Group Inc Stock (TMDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Transmedics Group Inc Stock (TMDX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Weill David | Director |
Dec 03 '25 |
Sale |
138.64 |
5,000 |
693,200 |
12,134 |
| Hernandez Gerardo | Chief Financial Officer |
Dec 04 '25 |
Sale |
139.62 |
920 |
128,450 |
15,064 |
0.62%
0.98%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):